CNS Pharmaceuticals Inc (CNSP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.22M
Last updated: Nov 17, 2026 at 10:56 AM ET
CNS Pharmaceuticals Inc (CNSP) Stock Forecast
Analysts expect CNS Pharmaceuticals (CNSP) to earn -$1.65 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.66.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss.
- Fiscal year ending Dec 31, 2026
- -$1.65
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$1.66
- EPS consensus
- Next report
- Mar 29, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.65 | -$1.65 to -$1.65 | 1 |
| Dec 31, 2027 | -$1.66 | -$1.66 to -$1.66 | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.28 | N/A | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$6.33.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.65 | -$3.67 | -$3.67 | -$3.67 | -$6.33 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.66 | -$2.89 | -$2.89 | -$2.89 | -$6.28 | N/A |
Frequently Asked Questions About CNSP
What is the CNSP stock forecast?
Consensus analyst estimates put CNS Pharmaceuticals's EPS at -$1.65 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from CNSP next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.65, with estimates from -$1.65 to -$1.65 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.66, with estimates from -$1.66 to -$1.66 from 1 analyst.
How many analysts cover CNSP?
1 analyst estimates EPS for CNS Pharmaceuticals for the fiscal year ending Dec 31, 2026.
CNSP pages: Overview, Earnings, Forecast, Financials, Competitors